CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells

Haibo Wang(Yangzhou University), Zhonglian Li(Tianjin Nankai Hospital)
Molecular Medicine Reports
May 29, 2015
Cited by 18


Related Papers